News
This was the stock's second consecutive day of losses.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
The stock's fall snapped a two-day winning streak.
Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...
The S&P 500 added 0.6% on Tuesday, June 10, 2025, as investors awaited developments in the trade negotiations between the U.S ...
US stock markets finished more or less flat on Monday, as investors took a breather with indices trading at their highest levels in nearly four months.
Regeneron Pharmaceuticals just got a haircut from Wall Street, with JPMorgan Chase & Co. lowering its price target from $950 ...
Sanofi (NASDAQ:SNY)’s shares fell 5% this week, even as the company announced positive results from its AERIFY-1 trial with ...
We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest’s Substack. In ...
13d
Zacks Investment Research on MSNREGN Strengthens Obesity Pipeline: Will the Move Revive the Stock?Regeneron Pharmaceuticals, Inc. REGN is looking to make inroads in the lucrative obesity market. The company recently entered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results